The pedal fungus reservoir

Archives of Dermatology

Volumn 142, Issue 10, 2006, Pages 1344-1346

  Daniel III, C Ralph ^b   Jellinek, Nathaniel J ^a  

^a BROWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS; DERMATOMYCOSIS; DERMATOPHYTE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CARRIER; EDITORIAL; FUNGUS CULTURE; HUMAN; IMMUNE DEFICIENCY; MOULD; ONYCHOMYCOSIS; PRIORITY JOURNAL; TINEA PEDIS; YEAST;

EID: 33750063468     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.10.1344     Document Type: Editorial

References (31)

1. Szepietowski JC, Reich A, Garlowska E, Kulig M, Baran E; Onychomycosis Epidemiology Study Group. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol. 2006;142:1279-1284.
2. Daniel CR, Elewski BE. The diagnosis of nail fungus infection revisited. Arch Dermatol. 2000;136:1162-1164.
3. Summerbell RC, Cooper E, Bunn U, Jamieson F, Gupta AK. Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol. 2005;43:39-59.
4. Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49:193-197.
5. Daniel CR, Elewski BE. Candida as a nail pathogen in healthy patients. J Miss State Med Assoc. 1995;36:379-381.
6. Daniel CR, Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol. 1998;37:904-907.
7. Daniel CR, Daniel MP, Daniel J, Sullivan S, Bell E. Managing chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant avoidance regimen. Cutis. 2004;73:81-85.
8. Tosti A, Piraccini BM, Ghetti E. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open randomized double-blind and double-dummy study. J Am Acad Dermatol. 2002;47:73-76.
9. Daniel CR, Norton LA, Scher RK. The spectrum of nail disease in patients with HIV infection. J Am Acad Dermatol. 1992;27:93-97.
10. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin. 2003;21:491-497.
11. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:539-542.
12. Gupta AK, Ryder JE, Baran R, Summerbell RC. Non-dermatophyte onychomycosis. Dermatol Clin. 2003;21:257-268.
13. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42:217-224.
14. Elewski BE, Leyden J, Rinaldi MG, Atillasoy E. Office-practice-based confirmation of onychomycosis: a US nationwide prospective survey. Arch Intern Med. 2002;162:2133-2138.
15. Ghannoum MA, Hajjeh RA, Scher R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641-648.
16. English MP. Nails and fungi. Br J Dermatol. 1976;94:697-701.
17. Cheng S, Chong L. A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong. Chin Med J (Engl). 2002;115:860-865.
18. Purim KSM, Bordignon GF, de Queiroz-Telles F. Fungal infection of the feet in soccer players and non-athlete individuals. Rev Iberoam Micol. 2005;22:34-38.
19. Ilkit M, Tanir F, Hazar S, Gumusay T, Akbaba M. Epidemiology of tinea pedis and toenail tinea unguium in worshippers in the mosques in Adana, Turkey. J Dermatol. 2005;32:698-704.
20. Brocks KM, Johansen UB, Jorgensen HO, Ravnborg LR, Svejgaard EL. Tinea pedis and onychomycosis in Danish soldiers before and after service in ex-Yugoslavia. Mycoses. 1999;42:475-478.
21. Perea S, Ramos MJ, Garau M, Gonzalez A, Noriega AR, del Palacio A. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol. 2000;38:3226-3230.
22. Ungpakorn R, Lohaprathan S, Reangchainam S. Prevalence of foot diseases in outpatients attending the Institute of Dermatology, Bangkok, Thailand. Clin Exp Dermatol. 2004;29:87-90.
23. Roseeuw D. Achilles foot screening project: preliminary results of patients screened by dermatologists. J Eur Acad Dermatol Venereol. 1999;12(suppl 1):S6-S9.
24. Burzykowski T, Molenberghs G, Abeck D, et al. High prevalence of foot diseases in Europe: results of the Achilles project. Mycoses. 2003;46:496-505.
25. Mohrenschlager M, Seidl HP, Schnopp C, Ring J, Abeck D. Professional hockey players: a high-risk group for fungal infections of the foot? Dermatology. 2001;203:271.
26. Erbagci Z, Tuncel AA, Zer Y, Balci I. A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents. Mycopathologia. 2005;159:347-352.
27. Zaias N, Rebell G. Chronic dermatomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;35:S17-S20.
28. Daniel CR, Lawson LA. Tinea unguium. Cutis. 1987;40:326-328.
29. Daniel CR. Traditional management of onychomycosis. J Am Acad Dermatol. 1996;35:S21-S25.
30. Daniel CR, Gupta A, Daniel MP, Daniel CM. Two feet-one hand syndrome: a retrospective multicenter survey. Int J Dermatol. 1997;36:658-660.
31. Strauss JS, Kligman AM. An experimental study of tinea pedis and onychomycosis of the foot. Arch Dermatol. 1957;76:71.